Group One Trading, L.P. Eiger Bio Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$1.02 - $7.48 $12,503 - $91,689	12,258 New	12,258 $14,000
Q2 2022 Aug 11, 2022	SELL	$4.99 - $8.96 $43,338 - $77,817	-8,685 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$3.84 - $9.74 $25,854 - $65,579	6,733 Added 344.93%	8,685 $72,000
Q4 2021 Feb 11, 2022	BUY	$5.12 - $8.19 $9,994 - $15,986	1,952 New	1,952 $10,000
Q4 2020 Feb 10, 2021	SELL	$7.98 - $12.29 $35,263 - $54,309	-4,419 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$7.96 - $12.42 $35,175 - $54,883	4,419 New	4,419 $36,000
Q2 2020 Aug 13, 2020	SELL	$5.4 - $13.37 $1,080 - $2,674	-200 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$9.77 - $15.66 $1,954 - $3,132	200 New	200 $3,000
Q3 2019 Nov 12, 2019	SELL	$9.59 - $12.0 $67 - $84	-7 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	7	7 $0

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.